Publications

Heidi Donovan, PhD, RN

Campbell G, Thomas TH, Hand L, Lee YJ, Taylor SE, Donovan HS. Caring for Survivors of Gynecologic Cancer: Assessment and Management of Long-term and Late Effects. Semin Oncol Nurs. 2019 Apr;35(2):192-201. doi: 10.1016/j.soncn.2019.02.006. PubMed PMID: 30867102.
Hand LC, Thomas TH, Belcher S, Campbell G, Lee YJ, Roberge M, Donovan HS. Defining Essential Elements of Caregiver Support in Gynecologic Cancers Using the Modified Delphi Method. J Oncol Pract. 2019 Apr;15(4):e369-e381. doi: 10.1200/JOP.18.00420. PubMed PMID: 30849004.
Taylor SE, Petschauer JS, Donovan H, Schorzman A, Razo J, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer. Int J Gynecol Cancer. 2019 Jan;29(1):147-152. doi: 10.1136/ijgc-2018-000055. PubMed PMID: 30640697.
Hay CM, Donovan HS, Campbell GB, Taylor SE, Wang L, Courtney-Brooks M. Chemotherapy in older adult gynecologic oncology patients: Can a phenotypic frailty score predict tolerance? Gynecol Oncol. 2019 Feb;152(2):304-309. doi: 10.1016/j.ygyno.2018.11.031. PubMed PMID: 30503049; PMCID: PMC6358476.
Hay CM, Donovan HS, Hartnett EG, Carter J, Roberge MC, Campbell GB, Zuchelkowski BE, Taylor SE. Sexual Health as Part of Gynecologic Cancer Care: What Do Patients Want? Int J Gynecol Cancer. 2018 Nov;28(9):1737-1742. doi: 10.1097/IGC.0000000000001376. PubMed PMID: 30358703.
Hand LC, Thomas TH, Belcher S, Campbell G, Lee YJ, Roberge M, Lizaso C, Sparacio D, Donovan HS. Caregiving Is a Marathon, Not a Road Race: Reenvisioning Caregiver Support Services in Gynecologic Oncology. Int J Gynecol Cancer. 2018 Nov;28(9):1722-1727. doi: 10.1097/IGC.0000000000001360. PubMed PMID: 30325785.
Donovan HS, Campbell GB. Persistent chemotherapy-induced peripheral neuropathy: Are dose reductions and drug modifications our only options? Gynecol Oncol. 2018 Jun;149(3):433-434. doi: 10.1016/j.ygyno.2018.05.003. PubMed PMID: 29861308.
Hagan TL, Gilbertson-White S, Cohen SM, Temel JS, Greer JA, Donovan HS. Symptom Burden and Self-Advocacy: Exploring the Relationship Among Female Cancer Survivors Clin J Oncol Nurs. 2018 Feb 1;22(1):E23-E30. doi: 10.1188/18.CJON.E23-E30. PubMed PMID: 29350706; PMCID: PMC5841467.
Hagan TL, Cohen SM, Rosenzweig MQ, Zorn K, Stone CA, Donovan HS. The Female Self-Advocacy in Cancer Survivorship Scale: A validation study. J Adv Nurs. 2018 Apr;74(4):976-987. doi: 10.1111/jan.13498. PubMed PMID: 29117439; PMCID: PMC5844819.
Belcher SM, Low CA, Posluszny DM, Schear R, Kramer RE, Donovan HS. Psychological Distress, Health Behaviors, and Benefit Finding in Survivors of Multiple Primary Cancers: Results From the 2010 Livestrong Survey. Oncol Nurs Forum. 2017 Nov 1;44(6):703-711. doi: 10.1188/17.ONF.703-711. PubMed PMID: 29052655.
Lee YJ, Arida JA, Donovan HS. The application of crowdsourcing approaches to cancer research: a systematic review. Cancer Med. 2017 Nov;6(11):2595-2605. doi: 10.1002/cam4.1165. PubMed PMID: 28960834; PMCID: PMC5673951.
Hagan TL, Cohen S, Stone C, Donovan H. Theoretical to Tangible: Creating a Measure of Self-Advocacy for Female Cancer Survivors. J Nurs Meas. 2016 Dec 1;24(3):428-441. doi: 10.1891/1061-3749.24.3.428. PubMed PMID: 28714448; PMCID: PMC5514617.
Hagan TL, Belcher SM, Donovan HS. Mind the Mode: Differences in Paper vs. Web-Based Survey Modes Among Women With Cancer. J Pain Symptom Manage. 2017 Sep;54(3):368-375. doi: 10.1016/j.jpainsymman.2017.07.005. PubMed PMID: 28711752; PMCID: PMC5610085.
Samuel CA, Turner K, Donovan HAS, Beckjord E, Cardy A, Dew MA, van Londen GJ. Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management. Support Care Cancer. 2017 Dec;25(12):3723-3731. doi: 10.1007/s00520-017-3799-0. PubMed PMID: 28681126; PMCID: PMC5688874.
Boele FW, van Uden-Kraan CF, Hilverda K, Weimer J, Donovan HS, Drappatz J, Lieberman FS, Verdonck-de Leeuw I, Sherwood PR. Neuro-oncology family caregivers' view on keeping track of care issues using eHealth systems: it's a question of time. J Neurooncol. 2017 Aug;134(1):157-167. doi: 10.1007/s11060-017-2504-y. PubMed PMID: 28550505; PMCID: PMC5543187.
Turner K, Samuel CA, Donovan HA, Beckjord E, Cardy A, Dew MA, van Londen GJ. Provider perspectives on patient-provider communication for adjuvant endocrine therapy symptom management. Support Care Cancer. 2017 Apr;25(4):1055-1061. doi: 10.1007/s00520-016-3491-9. PubMed PMID: 27864628; PMCID: PMC5363398.
Boele FW, Given CW, Given BA, Donovan HS, Schulz R, Weimer JM, Drappatz J, Lieberman FS, Sherwood PR. Family caregivers' level of mastery predicts survival of patients with glioblastoma: A preliminary report. Cancer. 2017 Mar 1;123(5):832-840. doi: 10.1002/cncr.30428. PubMed PMID: 27787881; PMCID: PMC5319890.
Hay CM, Courtney-Brooks M, Lefkowits C, Hagan TL, Edwards RP, Donovan HS. Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important? Gynecol Oncol. 2016 Nov;143(2):367-370. doi: 10.1016/j.ygyno.2016.08.235. PubMed PMID: 27531571; PMCID: PMC5077654.
Arida JA, Sherwood PR, Flannery M, Donovan HS. Representational Approach: A Conceptual Framework to Guide Patient Education Research and Practice. Oncol Nurs Forum. 2016 Nov 1;43(6):781-783. doi: 10.1188⁄16.ONF.781-783. PubMed PMID: 27768130.
Belcher SM, Hausmann EA, Cohen SM, Donovan HS, Schlenk EA. Examining the relationship between multiple primary cancers and psychological distress: A review of current literature. Psychooncology. 2017 Dec;26(12):2030-2039. doi: 10.1002/pon.4299. PubMed PMID: 27758055.
Campbell G, Hagan T, Gilbertson-White S, Houze M, Donovan H. Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study. Gynecol Oncol. 2016 Dec;143(3):578-583. doi: 10.1016/j.ygyno.2016.09.013. PubMed PMID: 27653982; PMCID: PMC5116395.
Davison J, Schenker Y, Donovan H, Rosenzweig M. A Work Sampling Assessment of the Nursing Delivery of Palliative Care in Ambulatory Cancer Centers. Clin J Oncol Nurs. 2016 Aug 1;20(4):421-6. doi: 10.1188/16.CJON.421-426. PubMed PMID: 27441515.
Hagan TL, Arida JA, Hughes SH, Donovan HS. Creating Individualized Symptom Management Goals and Strategies for Cancer-Related Fatigue for Patients With Recurrent Ovarian Cancer. Cancer Nurs. 2017 Jul/Aug;40(4):305-313. doi: 10.1097/NCC.0000000000000407. PubMed PMID: 27333127; PMCID: PMC5177540.
Lee YJ, Donovan H. Application of Text Mining in Cancer Symptom Management. Stud Health Technol Inform. 2016;225930-1. PubMed PMID: 27332415.
Gilbertson-White S, Sherwood P, Donovan H, King L. Use of Distress Screening To Identify Shorter Life Expectancy in Patients with Advanced Cancer Newly Referred to Palliative Care. J Palliat Med. 2016 Aug;19(8):800-1. doi: 10.1089/jpm.2016.0142. PubMed PMID: 27138467; PMCID: PMC4982945.
Gilbertson-White S, Campbell G, Ward S, Sherwood P, Donovan H. Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer. Cancer Nurs. 2017 Mar/Apr;40(2):117-123. doi: 10.1097/NCC.0000000000000376. PubMed PMID: 27088608; PMCID: PMC5065731.
Sherwood PR, Price TJ, Weimer J, Ren D, Donovan HS, Given CW, Given BA, Schulz R, Prince J, Bender C, Boele FW, Marsland AL. Neuro-oncology family caregivers are at risk for systemic inflammation. J Neurooncol. 2016 May;128(1):109-118. doi: 10.1007/s11060-016-2083-3. PubMed PMID: 26907491; PMCID: PMC4865431.
Donovan HS, Hagan TL, Campbell GB, Boisen MM, Rosenblum LM, Edwards RP, Bovbjerg DH, Horn CC. Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis. Support Care Cancer. 2016 Jun;24(6):2635-42. doi: 10.1007/s00520-015-3071-4. PubMed PMID: 26746209; PMCID: PMC4846512.
Sherwood PR, Cwiklik M, Donovan HS. Neuro-oncology family caregiving: review and directions for future research. CNS Oncol. 2016;5(1):41-8. doi: 10.2217/cns.15.43. PubMed PMID: 26675885; PMCID: PMC6078154.
Taylor SE, Li R, Petschauer JS, Donovan H, O'Neal S, Keeler AW, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer. Gynecol Oncol. 2015 Sep;138(3):548-53. doi: 10.1016/j.ygyno.2015.06.026. PubMed PMID: 26111788.
van Londen GJ, Donovan HS, Beckjord EB, Cardy AL, Bovbjerg DH, Davidson NE, Morse JQ, Switzer GE, Verdonck-de Leeuw IM, Dew MA. Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms. Oncol Nurs Forum. 2014 Nov 1;41(6):660-8. doi: 10.1188/14.ONF.660-668. PubMed PMID: 25355021; PMCID: PMC4500054.
Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L. Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. J Natl Cancer Inst. 2014 Jul;106(7): doi: 10.1093/jnci/dju128. PubMed PMID: 25006190; PMCID: PMC4110471.
King MT, Stockler MR, Butow P, O'Connell R, Voysey M, Oza AM, Gillies K, Donovan HS, Mercieca-Bebber R, Martyn J, Sjoquist K, Friedlander ML. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer. Int J Gynecol Cancer. 2014 Jun;24(5):865-73. doi: 10.1097/IGC.0000000000000167. PubMed PMID: 24844220.

<< Investigators Search

Top